News | 2012

05-03-2012 | reMYND launches a project aimed at improving the predictability of preclinical Alzheimer models as part of the prestigious Marie-Curie International Training Network NPlast

In the press | reMYND NV announced today its project in NPlast, a prestigious International Training Network funded by the European Commission that is to be launched April 27-28th 2012 at the Leibniz-Institut für Neurobiologie in Magdeburg, Germany.

Press release in Dutch.

31-01-2012 | reMYND receives a positive tax ruling on the income from its Roche collaboration

In the press | reMYND NV has received a positive ruling from the Belgian Tax Authorities. The ruling stipulates that the upfront license fee, all milestone payments and royalties linked to Roche Basel will qualify for the patent income deduction under Articles 205 WIB 92.

Newsletter

To receive regular updates, fill in your email address and we will keep you posted.

Select news by genre

Corporate

Drug discovery

Contract research